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HydrolysisBioavailability and biological properties of ﬂavonoid glycosides can be improved after the enzymatic
hydrolysis of speciﬁc glycosyl groups. In this study, we evaluate the antioxidant and antiproliferative
potential of rutin after enzymatic hydrolysis performed by a-L-rhamnosidases (hesperidinase from Pen-
icillium sp. and naringinase from Penicillium decumbens) previously heated at 70 C for 30 min to inacti-
vate the undesirable b-D-glucosidase activity. The highest in vitro antioxidant activity determined by
DPPH radical scavenging was achieved with rutin hydrolyzed by hesperidinase. Rutin was predominantly
bioconverted into quercetin-3-glucoside. There was no statistical difference between xanthine oxidase
inhibition by rutin before and after hydrolysis. However, in vitro inhibitory activity against ten human
tumor cell lines showed that hydrolyzed rutin exerted a more potent antiproliferative effect than quer-
cetin and rutin on various cancer cell lines, specially glioma, and ovarian and breast adenocarcinomas.
These results indicate that quercetin-3-glucoside could be a promising functional derivative obtained
by rutin hydrolysis.
 2013 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Rutin, also called rutoside, quercetin-3-O-rutinoside and sopho-
rin, is a ﬂavonoid glycoside consisting of the aglycone form, quer-
cetin bound at the C-3 position (on ring C) to a disaccharide
molecule, rutinose (C12H22O10), which is composed of one mole-
cule of rhamnose and one of glucose (Aherne & O’Brien, 2002). Ru-
tin is found in the fruit of fava d’anta tree (Dimorphandra mollis)
native to the Cerrado vegetation of Brazil, fruit rinds (especially cit-
rus fruits, such as orange, grapefruit, lemon and lime) and berries
such as mulberry, ash tree fruits and cranberries. It has been
reported that rutin has several pharmacological functions such as
antioxidant (Boyle et al., 2000), cytoprotective (Potapovich &
Kostyuk, 2003), vasoprotective (Tang et al., 2011), antiproliferative
(Santos et al., 2011), antithrombotic (Sheu, Hsiao, Chou, Shen, &
Chou, 2004) and cardioprotective activities (Ziaee, Zamansoltani,
Nassiri-Asl, & Abbasi, 2009). Quercetin is also an important dietary
ﬂavonoid with antioxidant, anti-inﬂammatory and antiprolifera-tive properties (Nijveldt et al., 2001) in addition to being an effec-
tive inhibitor of xanthine oxidase (Day, Bao, Morgan, &Williamson,
2000). Xanthine oxidase catalyzes the oxidation of hypoxanthine
and xanthine to uric acid, generating superoxide radicals, which
are involved in many pathological processes such as inﬂammation,
atherosclerosis, cancer, and aging (Paravicin & Touyz, 2008).
Previous work has shown that enzymatic hydrolysis of speciﬁc
glycosyl groups or the conversion of ﬂavonoid glycosides to agly-
cones increases anti-inﬂammatory activity of naringin (Amaro
et al., 2009) and antioxidant activity of kaempferol (Park, Rho,
Kim, & Chang, 2006), besides improving the bioavailability of hes-
peridin (Nielsen et al., 2006) and of ﬂavonoid glycosides in fruit
juices and green tea (Gonzáles-Barrio et al., 2004). The use of en-
zymes to modify the structure and improve the physicochemical
and biological properties of ﬂavonoids has been of great scientiﬁc
and industrial interest due to their wide availability, high selectiv-
ity, low cost and their promotion of efﬁcient reactions with few by-
products.
a-L-Rhamnosidases [E. C. 3.2.1.40] are glycosyl hydrolases
which cleave terminal a-L-rhamnose from natural glycosides. Only
two commercial preparations of a-L-rhamnosidases (naringinase
and hesperidinase) are available, and both are from fungal sources.
M.E.M.B. de Araújo et al. / Food Chemistry 141 (2013) 266–273 267Hesperidinase is obtained from species of Penicillium and Aspergil-
lus niger and naringinase is obtained from Penicillium decumbens.
All these preparations also show signiﬁcant b-D-glucosidase activ-
ity that catalyzes the hydrolysis of terminal non-reducing residues
with glucose release (Yadav, Yadav, & Yadav, 2010). Thus the activ-
ity of the a-L-rhamnosidases in the rutin substrate produces two
derivatives: quercetin-3-glucoside (isoquercetrin) and quercetin,
in proportions that depend on the reaction conditions.
Although there is a structural similarity to rutin, quercetin-3-
glucoside and quercetin, there are some noticeable differences in
physical, chemical and biological properties. Quercetin glycosides
show higher solubility in water than quercetin due to the hydro-
philicity of the sugar moieties (Aherne & O´Brien, 2002). In compar-
ison with rutin and quercetin, quercetin-3-glucoside is better
absorbed, suggesting that conjugation with glucose enhances quer-
cetin absorption in small intestine (Arts, Sesink, Faassen-Peters, &
Hollman, 2004). Indeed, previous reports have shown that querce-
tin-3-glucoside has a more potent antiproliferative effect than
quercetin or rutin (You, Ahn, & Ji, 2010). Thus, the synthesis of
mono-glycosylated quercetin from rutin by the enzymatic hydroly-
sis method seems to be a good alternative for obtaining com-
pounds with enhanced functional properties. Hesperidinase or
naringinase with inactivated b-D-glucosidase activity and express-
ing a-L-rhamnosidase activity allow the production of very expen-
sive ﬂavonoid glycosides, quercetin-3-glucoside, in an easy and
cheap bioprocess starting from rutin. In the present work, the
enzymatic hydrolysis of rutin by two commercial heat-treated gly-
cosyl hydrolases (hesperidinase and naringinase) was investigated
in order to obtain partially hydrolyzed rutin with enhanced
functional properties. Antioxidant properties using the 2,2-diphe-
nyl-1-picrylhydrazyl radical (DPPH), b-carotene bleaching and
xanthine oxidase (XO) inhibition activity were evaluated before
and after enzymatic treatment. Antiproliferative activity of querce-
tin and rutin before and after bioconversion were compared using
nine different cancer cell lines including glioma, chronic myeloid
leukemia and breast, ovarian, prostate, kidney, colon, and lung
cancer cells.
2. Materials and methods
2.1. Enzymes and reagents
Hesperidinase from Penicillium sp., naringinase from Penicillium
decumbens, xanthine oxidase from bovine milk, rutin (95% min.),
DPPH(2,2-diphenyl-1-picril-hydrazyl radical), p-Nitrophenyl a-L-
rhamnopyranoside (4-NRP), p-nitrophenyl b-D-glucopyranoside
(4-NGP), b-carotene (95%) rutin, quercetin-3-glucoside and querce-
tin standards were purchased from the Sigma–Aldrich Chemical
Co. All solvents and other reagents were of analytical, spectromet-
ric or chromatographic grade.
2.2. Inactivation kinetics
The activity of a-L-rhamnosidases naringinase and hesperidin-
ase was evaluated using 0.20 mM of p-nitrophenyl a-L-rhamnopyr-
anoside in 20 mM citrate buffer at pH 4.0, while the activity of
b-D-glucosidase was determined using 0.20 mM p-nitrophenyl
b-D-glucopyranoside in 20 mM citrate buffer at pH 4.0. An enzyme
concentration of 50 mg L1 in 0.05 M acetate buffer pH 4.0 was
used in these experiments. The concentration of free p-nitrophenol
produced after hydrolysis was evaluated spectrophotometrically
at k = 340 nm, using calibration curve of each compound. In order
to study b-D-glucosidase and a-L-rhamnosidase inactivation
kinetics of hesperidinase and naringinase, a temperature range of
50–80 C was used. The reaction was carried out in isothermal
conditions with shaking at 100 rpm for 30 min. Inactivation wasstopped by boiling (100 C) for 30 min. The control was enzyme
sample not submitted to thermal inactivation. One unit of
enzymatic activity (U) was deﬁned as the amount of enzyme that
liberated 1 lmol of free p-nitrophenol per minute under the above
assay conditions (U/min). The ratio of a-L-rhamnosidase activity to
b-D-glucosidase activity (Rha/Glu) was used to describe the
inactivation kinetics for b-D-glucosidase and a-L-rhamnosidase
activities.
2.3. Bioconversion reaction
Hesperidinase and naringinase solutions (50 mg L1in 0.05 M
acetate buffer pH 4.0) were heated at 70 C for 30 min to inacti-
vate glucosidase activity. The reaction mixtures containing
100 lL of enzyme preparation (50 mg L1) and 4 mL of a 1%m/v
rutin solution (dissolved previously in 1 mL of methanol) were
mixed and incubated for 2, 4, 8 and 12 h with shaking
(130 rpm) at 40 C. The reactions were stopped by boiling
(100 C) for 30 min, and samples were subsequently freeze-dried
and stored at 80 C prior to extraction and analysis. The assays
were performed in triplicate. Rutin incubated in the same condi-
tions without adding any enzyme and with unheated enzymes
were used as controls, aiming to evaluate the effects of heat
on enzyme activity.
2.4. UPLC–ESI-MS quantiﬁcation
After the conversion reactions, the freeze-dried products of
hydrolysis were dissolved in methanol, ﬁltered through a
0.22 lm syringe ﬁlter and analyzed by ultra-high performance
chromatography – mass spectrometry (UPLC–MS). Three lL of
each sample were analyzed on an Acquity UPLC system (Waters,
Milford,MA, USA) using a UPLC BEH column (2.1  50 mm,
1.7 lm particle size) at a temperature of 30 C. A gradient of (A)
deionized puriﬁed water with 1% formic acid and (B) methanol (Te-
dia, Brazil) starting with 5% B and ramping to 100% B at 8 min,
maintained till 8.50 min, then returning to initial conditions and
stabilizing by 10 min. Detection in negative ion modes was
achieved on an Acquity TQD mass spectrometer (Micromass
Waters, Milford, MA, USA) with capillary – 3000 V, Cone – 30 V,
source temperature 150 C; desolvation temperature 350 C.
2.5. Antioxidant activity
2.5.1. DPPH radical-scavenging activity
The antioxidant activity of samples was assessed on the basis of
scavenging activity of the stable 2, 2-diphenylpicrylhydrazyl free
radical (DPPH). 750 lL of a methanolic solution of DPPH
(0.02 mg/L) were added to 0.1 lmol of test samples in acetate buf-
fer 0.3 M, pH 3.8 or 120 lL of methanol, in the case of control.
Flasks were incubated at 25 C for 25 min and absorbance was
determined at 517 nm. All assays were performed in triplicate. A
solution of rutin in acetate buffer 0.3 M, pH 3.8 (0.75 mg/mL)
was used to calibrate the equipment. The scavenging capacity of
DPPH radical was calculated using the following equation:
DPPH scavenging effect ð%Þ ¼ ðAc  As=AcÞ  100;
where Ac and As are absorbance values of control reaction and test
samples, respectively.
2.5.2. b-Carotene bleaching method
The effect on lipid peroxidation inhibition was determined in a
b-carotene-oleic acid system according to the Miller (1971) meth-
od with adaptations. A mixture containing 50 lL of b-carotene
(2 mg/mL in chloroform), 40 lL of oleic acid standard, 1 mL of chlo-
roform and 400 mg of Tween 40 was prepared. Chloroform was
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tilled water were added. The mixture was then subjected to vigor-
ous shaking. In screw-top glasses, 225 ll of b-carotene/oleic acid
solution was added to 0.1 lmol of samples in acetate buffer
(0.3 M, pH 3.8) or 100 lL of methanol (blank assay). Absorbance
was read at 470 nm, at 0 min (immediately after emulsion addi-
tion) and after 120 min of incubation at 45 C (induction of thermal
oxidation). Peroxidation leads to the bleaching of the b-carotene
molecule, so the higher the absorbance the higher the antioxidant
activity. The degradation rate was calculated according to zero or-
der reaction kinetics. Inhibition of lipid peroxidation was calcu-
lated according to the following equation:
% inhibition ¼ ½1 ðA0  A1Þ=ðA00  A01Þ  100;
where A0 is the absorbance of sample at zero time, A1 is the absor-
bance of sample after incubation (120 min) at 45 C, A00 is the absor-
bance of control at zero time and A01 is the absorbance of control
after incubation (120 min) at 45 C.
2.5.3. Determination of xanthine oxidase (XO) inhibition
Xanthine oxidase activity was determined by measuring the
formation of uric acid from xanthine. Xanthine in phosphate buffer
0.1 M, pH 7.4 (1.3 lmol) was incubated with 100 lL of ethanol and
test samples (90 lM). The mixtures were pre-incubated at 37 C,
for 10 min. XO (0.1 U/mL) was then added to the mixtures and
the ﬂasks were incubated at 37 C for 20 min. Enzymatic reaction
was stopped by adding 25 lL of 3.2% hydrochloric acid. Absorbance
was determined at 290 nm. Phosphate buffer (0.1 M, pH 7.4) was
used as blank and a solution containing xanthine and xanthine oxi-
dase, at same conditions previously described, as used as reaction
control. All assays were performed in duplicate. Xanthine oxidase
inhibition (XO inhibition) was calculated as follows:
XO inhibitionð%Þ ¼ ð1 As=AcÞ  100;
where Ac and As are the absorbance values of reaction control and
tested samples, respectively.
2.6. Determination of antiproliferative activity
Nine human cancer cell lines [U251 (glioma, CNS), MCF-7
(breast), NCI-ADR/RES (ovarian expressing phenotype multiple
drugs resistance), 786–0 (kidney), NCI-H460 (lung, non-small
cells), PC-3 (prostate), OVCAR-03 (ovarian), HT-29 (colon adeno-
carcinoma) and K-562 (chronic myeloid leukemia)] were kindly
provided by Frederick Cancer Research & Development Center –
National Cancer Institute – Frederick, MA, USA. Stock cultures were
grown in 5 mL of RPMI-1640 (GIBCO BRL) supplemented with 5%
fetal bovine serum (FBS, GIBCO BRL). Penicillin: streptomycin mix-
ture 1000 U/mL:1000 lg/mL (1 mL/L RPMI-1640) was added to
experimental cultures. Cells in 96-well plates (100 lL cells/well)
were exposed to different concentrations of samples (0.25, 2.5,
25 and 250 lg/mL) in DMSO/RPMI/FBS 5% at 37 C, 5% CO2, for
48 h. Final DMSO concentration did not affect cell viability. Cells
were then ﬁxed with trichloroacetic acid solution (50%, v/v) and
cell proliferation was determined by spectrophotometric quantiﬁ-
cation (540 nm) of cellular protein content using sulforhodamine B
assay (Monks et al., 1991). Doxorubicin (DOX; 0.025–25 lg/mL)
was used as a positive control. Three measurements were ob-
tained: at the beginning of incubation (To) and 48 h post-incuba-
tion for compound-free (C) and tested (T) cells. The choice of
48 h incubation was based on the NCI60 protocol, proposed by
NCI/EUA for antiproliferative screening. Cell proliferation was
determined according to the equation 100  [(T  To)/C–To]. Cyto-
static effect was observed when To 6 T < C while cytocidal effect
occurred when T < To. From the concentration–response curve foreach cell line, TGI value (concentration that produces 0% cell
growth or totally cytostatic effect) was determined through non-
linear regression analysis using the software Origin 8.0 (OriginLab
Corporation). The experiments were done in triplicate.
2.7. Statistical analysis
All the experiments were performed in triplicate, and the data
were expressed as means ± the standard deviation. The statistical
signiﬁcance of the analytical results was assessed by ANOVA, and
the differences identiﬁed were pinpointed by an unpaired Stu-
dent’s t-test. An associated probability (p value) of less than 5%
was considered signiﬁcant.3. Results
3.1. Effects of heat on enzyme activity
The heat stability of a-L-rhamnosidase and b-D-glucosidase
were investigated at 50, 60, 70 and 80 C for 30 min (Fig. 1). b-D-
glucosidase activity decreased more rapidly than a-L-rhamnosi-
dase activity with heat treatment. Although heating at 70 C for
30 min leads to a signiﬁcant reduction on a-L-rhamnosidase activ-
ity of hesperidinase and naringinase compared to the activity at
50 C (from 4.2 to 2.6 and 3.7 to 2.1 U/min, respectively), the ratio
of a-L-rhamnosidase activity to b-D-glucosidase activity (Rha/Glu)
was highest at 70 C for both enzymes. Once b-D-glucosidase had
been selectively inactivated at 70 C for 30 min, the residual a-L-
rhamnosidase activity of the enzymes was used for the production
of mono-glycoside ﬂavonoids starting from rutin.
3.2. Analysis of the reaction products by UPLC–MS
Quercetin-3-glucoside was detected by UPLC–MS in negative
ion mode, as a peak at 5.4 min (m/z 463) which corresponded to
its deprotonated ion [M – H], and conﬁrmed by comparison of
the retention time and MS/MS fragments of a standard of querce-
tin-3-glucoside. UPLC–MS analysis of hydrolyzed rutin after 2h-
hesperidinase reaction furnished a conversion of 48% of rutin into
quercetin-3-glucoside (Fig. 2 and Fig. 3A) while after 4h-reaction,
the conversion increased to 69.5% of quercetin-3-glucoside and
7.5% of quercetin (Fig. 2 and Fig. 3B). More than 4 h hydrolysis
did not increase quercetin-3-glucoside production. The Fig. 3C
show MS proﬁles in the negative mode of quercetin-3-glucoside
produced after 4 h of treatment enzymatic with hesperidinase.
Only 34.5% of quercetin-3-glucoside was detected after 4 h of reac-
tion using naringinase in identical conditions (data not shown),
which explains the lower values for antioxidant activity obtained
after bioconversion using naringinase.
3.3. The inﬂuence of rutin bioconversion on antioxidant capacity
In order to investigate the efﬁciency of enzymatic treatment of
rutin in its antioxidant capacity, in vitro methods were used as
summarized in Table 1. The DPPHd method was used to evaluate
hydrogen donating ability, and the antioxidant capacity was ex-
pressed as the percentage of DPPHdradical-scavenging activity as
compared to the control. The antioxidant capacity of the rutin in-
creased by approximately 30% after 4 h of treatment with hesperi-
dinase, while with the use of naringinase, only a slight increase
was observed (approximately 10%). The values obtained show a
pattern similar to that of quercetin, well-known for its powerful
antioxidant properties. These results suggested that rutin biocon-
version catalyzed by hesperidinase was more effective than
that promoted by naringinase. Hydrolyzed rutin produced by
Fig. 1. Effect of temperature on b-D-glucosidase and a-L-rhamnosidase activities of naringinase and hesperidinase. The ratio of the two enzyme activities is represented as
Rha/Glu.
Fig. 2. Concentrations of rutin, quercetin-3-glucoside and quercetin after enzy-
matic treatment with hesperidinase. Data are mean ± SD (n = 3).
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investigation.
The b-carotene bleaching method is widely used since it does
not require high temperatures use, and antioxidant capacity of
heat-sensitive ﬂavonoids can be readily determined and quantita-
tively evaluated. The determination of the antioxidant activity of
samples is based on their capacity to inhibit the b-carotene bleach-
ing caused by free radicals generated during linoleic acid peroxida-
tion. There was no signiﬁcant increase in the antioxidant capacity
of the hydrolyzed rutin after the reaction catalyzed by both en-
zymes, when evaluated using b-carotene bleaching method. How-
ever the quercetin standard showed a higher percentage of
oxidation inhibition, possibly due to its more hydrophobic nature.
The XO inhibitory capacity of hydrolyzed rutin (after 4, 8 and
12 h of hydrolysis with hesperidinase) was not statistically differ-
ent from rutin, which could be considered a weak inhibitor of
XO. Quercetin, on the other hand, exhibited the strongest inhibi-
tory activity, as shown in Table 1.
3.4. Antiproliferative activity in vitro
The antiproliferative properties of the samples before and after
bioconversion were assessed using nine human cancer cell lines,
and the chemotherapeutic drug, doxorubicin, as a positive control
(Fig. 4 and Table 2). A horizontal line at 0% was traced to visualize
Total Growth Inhibition (TGI) that represents the concentration
required to completely inhibit cell growth (total cytostatic
effect) (Table 2). For all cell lines tested, rutin hydrolyzed by
hesperidinase displayed a moderate antiproliferative activity with
selectivity for OVCAR-3 (ovarian, TGI = 1.5 lg/mL), MCF-7 (breast,
TGI = 2.3 lg/mL) and U251 (glioma, TGI = 3.6 lg/mL) while querce-
tin presented a weak activity with selectivity for U251 (glioma,
TGI = 31.4 lg/mL), MCF-7 (breast, TGI = 31.9 lg/mL), 786–0 (renal,
TGI = 42.7 lg/mL) and NCI-ADR/RES (ovarian expressing multidrug
resistance, TGI = 44.0 lg/mL). Rutin did not inhibit cell prolifera-
tion of any of the cancer cell lines tested.4. Discussion
Flavonoid glycosides production of by removing rhamnose from
rutinosides can be performed through controlled enzymatic catal-ysis. In the present study, we were able to deﬁne a good condition
of b-D-glucosidase inactivation for hesperidinase and naringinase,
while keeping a high level of a-L-rhamnosidase activity. After 4 h
of enzymatic reaction catalyzed by hesperidinase, previously
heated at 70 C for 30 min, signiﬁcant amounts of quercetin-3-glu-
coside (approximately 70%) were obtained. Hesperidinase hydro-
lyzed rutin more efﬁciently than naringinase. Hydrolyzed rutin
produced by bioconversion using hesperidinase was subsequently
selected for further investigation.
Vila-Real, Alfaia, Bronze, Calado, and Ribeiro (2011) performed a
similar procedure to produce ﬂavonoid monoglycosides, including
quercetin-3-glucoside, from rutinosides, using naringinase from
Penicillium decumbens as biocatalyst. The authors reported that a
selective inactivation of b-D-glucosidase activity of naringinase
was achieved at 81.5 C and pH 3.9, keeping a very high residual
activity of a-L-rhamnosidase (78%). Similarly, You et al. (2010) re-
ported that b-D-glucosidase activity of crude enzyme extract of
Aspergillus niger was completely inactivated by treatment for
30 min at 70 C while the a-L-rhamnosidase activity was decreased
by only 50%.
Fig. 3. UPLC–MS chromatogram (A and B) of rutin after of 2 and 4 h of enzymatic treatment with heat-treated hesperidinase. Negative ion mode MS of quercetin 3-glucoside
(C) produced after 4 h of enzymatic treatment with hesperidinase.
Table 1
Antioxidant activity of rutin control, hydrolyzed rutin (bioconversion with hesperidinase and naringinase) and standard quercetin determined by DPPH and b-carotene-linoleic
acid method and xanthine oxidase inhibition of rutin control, hydrolyzed rutin (bioconversion with hesperidinase) and standard quercetin.
Samples Time of bioconversion
reaction (h)
DPPHd scavenging effect (%) b-Carotene
(% oxidation inhibition)
Xanthine oxidase
inhibition (%)
Rutin (control) 62.6 ± 6.9a 49.4 ± 2.7a 16.7 ± 8.7a
Hydrolyzed rutin (bioconversion with hesperidinase) 4 81.4 ± 2.3b 47.1 ± 7.5a 21.8 ± 8.6a
8 72.4 ± 6.6a 50.1 ± 3.9a 29.5 ± 8.0a
12 79.3 ± 1.3b 57.2 ± 7.9a 29.7 ± 11.0a
Hydrolyzed rutin (bioconversion with naringinase) 4 70.3 ± 3.9a 50.5 ± 5.4a
8 68.4 ± 3.6a 50.4 ± 4.6a
12 70.3 ± 5.2a 52.2 ± 3.9 a
Quercetin (standard) 89.8 ± 2.5b 78.1 ± 2.7b 79.3 ± 7.2b
The results were presented in mean ± standard deviation, and those with different letters in the same column are signiﬁcantly different compared to rutin before biocon-
version (p < 0.05).
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ase and naringinase (Fig. 1) could explain the slight increase in
DPPH scavenging (Table 1) observed for hydrolyzed rutin obtained
by bioconversion with heat-treated hesperidinase in comparison
with hydrolyzed rutin obtained by bioconversion with heat-trea-
ted naringinase. On the other hand, using the b-carotene bleaching
method both hydrolytic products afforded a similar result to that of
rutin (Table 1).Many in vitro and in vivo studies related quercetin bioactivities
and correlated with its glycosides, showing differences in effective-
ness of these compounds. Our ﬁndings have shown that quercetin-
3-glucoside, at the concentration obtained by heat-treated hesperi-
dinase treatment, has an antioxidant activity comparable to that
observed for quercetin and considerably greater than that of rutin
when evaluated using DPPH method (Table 1). This is in line with
other studies comparing the antiradical activity of quercetin and
Fig. 4. Antiproliferative activity of rutin control (A), quercetin (B) and hydrolyzed rutin (C) obtained after 4 h of enzymatic treatment with hesperidinase, against nine
cancerous cell lines: j U251 (glioma), N MCF-7 (breast adenocarcinoma); . NCI-ADR/RES (ovarian expressing multidrug resistance); J 786-O (kidney adenocarcinoma);
I NCI-H460 (non-small cells lung adenocarcinoma);  PC-3 (prostate adenocarcinoma); NIH:OVCAR-3 (ovarian adenocarcinoma); d HT-29 (colon adenocarcinoma) and
H K-562 (chronic myeloid leukemia).
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Table 2
Values of Total Growth Inhibition (TGI) (lg/mL) in each cell line tested for doxorubicin, rutin, quercetin and hydrolyzed rutin (obtained after 4 h of bioconversion with heat-
treated hesperidinase).
U251a MCF-7b NCI-ADR/RESc 786-0d NCI-H460e PC-3f OVCAR-3g HT-29h K562i
Doxorubicin 0.025 <0.025 0.90 0.90 <0.025 0.069 0.033 0.091 0.032
Rutin (control) >250 >250 >250 >250 >250 >250 >250 >250 >250
Hydrolyzed rutin 3.6 2.3 7.9 8.6 5.7 5.4 1.5 24.4 4.8
Quercetin 31.4 31.9 44.0 42.7 70.5 72.7 72.7 >250 >250
a Glioma.
b Breast adenocarcinoma.
c Ovarian expressing multidrug resistance.
d Kidney adenocarcinoma.
e Non-small cells lung adenocarcinoma.
f Prostate adenocarcinoma.
g Ovarian adenocarcinoma.
h Colon adenocarcinoma.
i Chronic myeloid leukemia.
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ation at C(40)-OH markedly decreased the H-donating ability
(Goupy, Dufour, Loonis, & Dangles, 2003), while C(3)-OH deriva-
tives of quercetin showed reducing potential comparable with that
of free aglycone (Burda & Oleszek, 2001).
On the other hand, when evaluated by the b-carotene method,
bioconversion failed to promote any enhancement on the antioxi-
dant capacity, as only ﬂavonols with a free hydroxyl group at the C-
3 position of the ﬂavonoid skeleton show high inhibitory activity to
b-carotene oxidation. Furthermore, quercetin glycosides are more
hydrophilic than quercetin. This modiﬁes the coefﬁcients of distri-
bution between aqueous and lipid phases, which is of great signif-
icance in lipid systems such as TEAC or b-carotene emulsions
(Burda & Oleszek, 2001).
Our results had also suggested that the enzymatic product ob-
tained, containing almost 70% of quercetin-3-glucoside, showed
no signiﬁcant difference in xanthine oxidase inhibition when com-
pared to rutin, while quercetin showed the highest inhibitory
activity (Table 1). According to literature, rutin has a much lower
activity in a xanthine/xanthine oxidase system despite a free
C(40)-OH group in the B-ring (Masuoka, Matsuda, & Kubo, 2012).
In other model systems, quercetin derivatives had been also dem-
onstrated displaying a lower antioxidant activity in comparison
with free aglycone (Burda & Oleszek, 2001) suggesting that the
lower antioxidant activity of quercetin derivatives could be mainly
due to hydroxyl groups blocked by sugar or alkoxyl substituents.
There is also evidence that XO inhibition by ﬂavonoids depends
on location and number of hydroxyl groups in molecule. The stron-
gest contribution towards XO inhibition seems to be result from
introduction of a 5-hydroxyl or 7-hydroxyl moiety into a ﬂavone
backbone, while 20-hydroxyl and 3-hydroxyl groups result in neg-
ative contribution to XO inhibition (Nijveldt et al., 2001).
In vitro inhibitory activity against human tumor cells showed
that hydrolyzed rutin exerted a more potent antiproliferative effect
than quercetin and rutin on various cancer cell lines, showing high-
er activity for ovarian adenocarcinoma (OVCAR-3, TGI = 1.5 lg/
mL), breast adenocarcinoma (MCF-7, TGI = 2.3 lg/mL) and glioma
(U251, TGI = 3.6 lg/mL) (Fig. 4 and Table 2). The most potent anti-
proliferative effect observed for this quercetin-3-glucoside mixture
might be related to the speciﬁc transport system, glucose transport
carrier SGLT1. It was reported that glucose conjugation to a phenyl
compound resulted in active absorption frommucosal side to sero-
sal side by glucose transport system (Mizuma, Ohta, Hayashi, &
Awazu, 1992). Experimental evidence has suggested that querce-
tin-3-glucoside and quercetin-40-glucoside can be transported by
sodium-dependent glucose transporter (SGLT1) and subsequently
deglycosylated within enterocyte by cytosolic b-glucosidase
(Wolffram, Blöck, & Ader, 2002). Quercetin itself was not trans-
ported by SGLT1 or GLUT2 (Kwon et al., 2007). Quercetin, but notrutin, has been shown to express anti-proliferative effects on the
human colon cancer cell line (HT-29), in a dose-dependent and
time-dependent manner (Kim, Bang, & Kim, 2005). You et al.
(2010) recently related that quercetin-3-glucoside produced by re-
moval of rhamnose sugar by crude enzyme extract of Aspergillus ni-
ger showed growth-inhibitory effects in colon (HT-29 and HCT
116), breast (MCF-7), hepatocellular (HepG2), and lung cancer
(A549) cells with the IC50 value between 15 and 25 lM, while
quercetin was greater than 80 lM. Quercetin-3-glucoside is not
an abundant ﬂavonol glycoside in foods; however, its bioavailabil-
ity has been shown to be one and a half times greater than querce-
tin in rats (Morand, Manach, Crespy, & Remesy, 2000) and in dogs
(Reinboth, Wolffram, Abraham, Ungemach, & Cermak, 2010). On
the other hand, investigations of protective mechanism of querce-
tin and its derivatives against oxidative damage of in vitro rat C6
glioma cells showed that quercetin to be an active cell protector
but not rutin or quercetin-3-glucoside (Chen, Jeng, Lin, Wu, & Chen,
2006).5. Conclusion
The enzymatic reaction catalyzed by heated hesperidinase from
Penicillium sp. efﬁciently converted rutin into its mono-glycoside
form, quercetin-3-glucoside. Quercetin-3-glucoside and quercetin
showed similar antioxidant capacity as evaluated by DPPH assay,
but quercetin-3-glucoside showed lower inhibitory effects on xan-
thine oxidase and as antioxidant when evaluated by the b-carotene
assay. However, this derivative exerted a more potent antiprolifer-
ative effect than quercetin or rutin on various cancer cell lines. The
results obtained from this study indicate that quercetin-3-gluco-
side could be a promising functional derivative obtained by rutin
hydrolysis and further in vivo evaluations are needed.Acknowledgements
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